These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

548 related items for PubMed ID: 22529220

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.
    Athanasakis K, Igoumenidis M, Karampli E, Vitsou E, Sykara G, Kyriopoulos J.
    Clin Ther; 2012 Aug; 34(8):1803-14. PubMed ID: 22818870
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cost analysis of varenicline versus bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua.
    Lutz MA, Lovato P, Cuesta G.
    Hosp Pract (1995); 2012 Feb; 40(1):35-43. PubMed ID: 22406881
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Adverse effects and tolerability of medications for the treatment of tobacco use and dependence.
    Hays JT, Ebbert JO.
    Drugs; 2010 Dec 24; 70(18):2357-72. PubMed ID: 21142259
    [Abstract] [Full Text] [Related]

  • 9. Nicotine dependence and smoking cessation.
    Tan L, Tang Q, Hao W.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Nov 24; 34(11):1049-57. PubMed ID: 19952392
    [Abstract] [Full Text] [Related]

  • 10. The neurobiological basis for partial agonist treatment of nicotine dependence: varenicline.
    Foulds J.
    Int J Clin Pract; 2006 May 24; 60(5):571-6. PubMed ID: 16700857
    [Abstract] [Full Text] [Related]

  • 11. Comparative Effectiveness of Smoking Cessation Medications: A National Prospective Cohort From Taiwan.
    Chang PY, Lo PC, Chang HC, Hsueh KC, Tsai YW.
    PLoS One; 2016 May 24; 11(11):e0166992. PubMed ID: 27893843
    [Abstract] [Full Text] [Related]

  • 12. General practitioners' beliefs about effectiveness and intentions to prescribe smoking cessation medications: qualitative and quantitative studies.
    Vogt F, Hall S, Marteau TM.
    BMC Public Health; 2006 Nov 08; 6():277. PubMed ID: 17092346
    [Abstract] [Full Text] [Related]

  • 13. Did the introduction of varenicline in England substitute for or add to the use of other smoking cessation medications?
    Kotz D, Fidler JA, West R.
    Nicotine Tob Res; 2011 Sep 08; 13(9):793-9. PubMed ID: 21543548
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
    Nides M, Oncken C, Gonzales D, Rennard S, Watsky EJ, Anziano R, Reeves KR.
    Arch Intern Med; 2011 Sep 08; 166(15):1561-8. PubMed ID: 16908788
    [Abstract] [Full Text] [Related]

  • 16. Cost effectiveness of varenicline in Belgium, compared with bupropion, nicotine replacement therapy, brief counselling and unaided smoking cessation: a BENESCO Markov cost-effectiveness analysis.
    Annemans L, Nackaerts K, Bartsch P, Prignot J, Marbaix S.
    Clin Drug Investig; 2009 Sep 08; 29(10):655-65. PubMed ID: 19715382
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.